Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is a severe complication of chronic hepatitis B virus (HBV) infection. HCC can still develop in CHB patients undergoing antiviral therapy. Although several scoring systems for the prediction of HCC risk in CHB patients are available, very few of them ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chih-Lang, Wu, Szu-Yuan, Lai, Ming-Wei, Hsu, Chao-Wei, Chen, Wan-Ming, Jao, An-Tzu, Chien, Cheng-Hung, Hu, Ching-Chih, Chien, Rong-Nan, Yeh, Chau-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340409/
https://www.ncbi.nlm.nih.gov/pubmed/37444453
http://dx.doi.org/10.3390/cancers15133343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340409/
https://www.ncbi.nlm.nih.gov/pubmed/37444453
http://dx.doi.org/10.3390/cancers15133343

Ejemplares similares